A nonrandomized open-label phase 2 trial of nonischemic heart preservation for human heart transplantation

A nonrandomized open-label phase 2 trial of nonischemic heart preservation for human heart transplantation

Ischemia and reperfusion damage contribute to early graft dysfunction and recipient’s death. Here the authors show the feasibility and safety of a non-ischemic heart preservation method for heart transplantation in a non-randomized trial.

Guardado en:
Detalles Bibliográficos
Autores principales: Johan Nilsson, Victoria Jernryd, Guangqi Qin, Audrius Paskevicius, Carsten Metzsch, Trygve Sjöberg, Stig Steen
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2020
Materias:
Science
Q
Acceso en línea:https://doaj.org/article/f39aecfe4ca9407ca1f37c429ffaeb07
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:f39aecfe4ca9407ca1f37c429ffaeb07
record_format dspace
spelling oai:doaj.org-article:f39aecfe4ca9407ca1f37c429ffaeb072021-12-02T17:30:52ZA nonrandomized open-label phase 2 trial of nonischemic heart preservation for human heart transplantation10.1038/s41467-020-16782-92041-1723https://doaj.org/article/f39aecfe4ca9407ca1f37c429ffaeb072020-06-01T00:00:00Zhttps://doi.org/10.1038/s41467-020-16782-9https://doaj.org/toc/2041-1723Ischemia and reperfusion damage contribute to early graft dysfunction and recipient’s death. Here the authors show the feasibility and safety of a non-ischemic heart preservation method for heart transplantation in a non-randomized trial.Johan NilssonVictoria JernrydGuangqi QinAudrius PaskeviciusCarsten MetzschTrygve SjöbergStig SteenNature PortfolioarticleScienceQENNature Communications, Vol 11, Iss 1, Pp 1-8 (2020)
institution DOAJ
collection DOAJ
language EN
topic Science
Q
spellingShingle Science
Q
Johan Nilsson
Victoria Jernryd
Guangqi Qin
Audrius Paskevicius
Carsten Metzsch
Trygve Sjöberg
Stig Steen
A nonrandomized open-label phase 2 trial of nonischemic heart preservation for human heart transplantation
description Ischemia and reperfusion damage contribute to early graft dysfunction and recipient’s death. Here the authors show the feasibility and safety of a non-ischemic heart preservation method for heart transplantation in a non-randomized trial.
format article
author Johan Nilsson
Victoria Jernryd
Guangqi Qin
Audrius Paskevicius
Carsten Metzsch
Trygve Sjöberg
Stig Steen
author_facet Johan Nilsson
Victoria Jernryd
Guangqi Qin
Audrius Paskevicius
Carsten Metzsch
Trygve Sjöberg
Stig Steen
author_sort Johan Nilsson
title A nonrandomized open-label phase 2 trial of nonischemic heart preservation for human heart transplantation
title_short A nonrandomized open-label phase 2 trial of nonischemic heart preservation for human heart transplantation
title_full A nonrandomized open-label phase 2 trial of nonischemic heart preservation for human heart transplantation
title_fullStr A nonrandomized open-label phase 2 trial of nonischemic heart preservation for human heart transplantation
title_full_unstemmed A nonrandomized open-label phase 2 trial of nonischemic heart preservation for human heart transplantation
title_sort nonrandomized open-label phase 2 trial of nonischemic heart preservation for human heart transplantation
publisher Nature Portfolio
publishDate 2020
url https://doaj.org/article/f39aecfe4ca9407ca1f37c429ffaeb07
work_keys_str_mv AT johannilsson anonrandomizedopenlabelphase2trialofnonischemicheartpreservationforhumanhearttransplantation
AT victoriajernryd anonrandomizedopenlabelphase2trialofnonischemicheartpreservationforhumanhearttransplantation
AT guangqiqin anonrandomizedopenlabelphase2trialofnonischemicheartpreservationforhumanhearttransplantation
AT audriuspaskevicius anonrandomizedopenlabelphase2trialofnonischemicheartpreservationforhumanhearttransplantation
AT carstenmetzsch anonrandomizedopenlabelphase2trialofnonischemicheartpreservationforhumanhearttransplantation
AT trygvesjoberg anonrandomizedopenlabelphase2trialofnonischemicheartpreservationforhumanhearttransplantation
AT stigsteen anonrandomizedopenlabelphase2trialofnonischemicheartpreservationforhumanhearttransplantation
AT johannilsson nonrandomizedopenlabelphase2trialofnonischemicheartpreservationforhumanhearttransplantation
AT victoriajernryd nonrandomizedopenlabelphase2trialofnonischemicheartpreservationforhumanhearttransplantation
AT guangqiqin nonrandomizedopenlabelphase2trialofnonischemicheartpreservationforhumanhearttransplantation
AT audriuspaskevicius nonrandomizedopenlabelphase2trialofnonischemicheartpreservationforhumanhearttransplantation
AT carstenmetzsch nonrandomizedopenlabelphase2trialofnonischemicheartpreservationforhumanhearttransplantation
AT trygvesjoberg nonrandomizedopenlabelphase2trialofnonischemicheartpreservationforhumanhearttransplantation
AT stigsteen nonrandomizedopenlabelphase2trialofnonischemicheartpreservationforhumanhearttransplantation
_version_ 1718380765593468928

Ejemplares similares